ClinicalTrials.gg
RecruitingNCT06506201Updated Jul 18, 2025

Legs Dysmetria in Total Hip Replacement: Does Hip Approacches and Navigation Decrease the Risk?

An interventional study of Velys hip navigation and Standard of care in Hip Osteoarthritis, sponsored by Istituto Ortopedico Rizzoli. Recruiting at 1 site in Italy. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-07-18.

Sponsored by Istituto Ortopedico Rizzoli · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Osteoarthritis, Hip by Istituto Ortopedico Rizzoli — 3 open to participants now, 3 under way, none of them phase 3. Osteoarthritis, Hip · Istituto Ortopedico Rizzoli.

Started
2024
with 1 other
No phase
9 of 13
2 open now
Registered
13th of 13
by date

Among the 13 studies in Osteoarthritis, Hip by Istituto Ortopedico Rizzoli, this one is one of 2 that started in 2024, is one of 9 with no phase, and was the 13th registered.

Osteoarthritis, Hip

642 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.

Browse Osteoarthritis, Hip studies →

Open to participants now

3 of the 13 studies in Osteoarthritis, Hip by Istituto Ortopedico Rizzoli are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 86 Osteoarthritis, Hip studies recruiting now, 53 (62%) set no upper age limit and 7 (8%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 50 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Osteoarthritis, Hip by Istituto Ortopedico Rizzoli, or all of them as a file.
02

Study summary

The purpose of this study is to collect clinical and radiological data from the case series of patients surgically treated with total hip arthroplasty at the Rizzoli Orthopaedic Institute.

The primary objective is to evaluate in terms of safety and efficacy the reduction of legs dysmetria and proper acetabular cup inclination intraoperatively when comparing anterior, direct lateral, and postero-lateral hip approaches conducted via traditional or navigation-assisted surgery.

The secondary objectives of the study are to evaluate, by comparing navigation-assisted and non-navigation-assisted hip approaches, intraoperatively the correct positioning of the prosthesis by analyzing the acetabular cup version; surgical timing; and number of intraoperative radiographs taken. In addition, the accuracy of preoperative planning will be assessed and a clinical evaluation performed during a follow-up of one year.

03

Conditions studied

  • Hip Osteoarthritis

Browse trials for

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age between 50 and 80 years;
  2. Signs and symptoms of hip osteoarthritis (pain intensity of at least 6 points of visual analogic scale pain - 0-10 scale in the previous week);
  3. Radiographic signs of hip osteoarthritis (Grade 3-4 according to Tonnis classification);

Exclusion criteria

Exclusion Criteria:

  1. Patients unable to express consent;
  2. Patients undergoing previous ipsilateral hip surgery;
  3. Patients undergoing lower limb surgery to be treated in the previous 12 months;
  4. Patients with malignant neoplasms;
  5. Patients with rheumatic diseases;
  6. Patients with uncontrolled diabetes;
  7. Patients with uncontrolled thyroid metabolic disorders;
  8. Patients abusing alcoholic beverages, drugs or medications;
  9. > 35;
  10. Pregnant and/or fertile women.
  11. Pain intensity less than 6 points in accordance with the visual analogic scale scale.
  12. Patients with the presence of excessive deformity resulting from acetabular or femoral head dysplasia
  13. Patients who have already undergone total hip arthroplasty surgery on the affected hip.
  14. Previous extensive surgery of the reference joint (osteotomy around the hip, open or arthroscopic osteochondroplasty for femoral-acetabular conflict).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
136 participants (estimated)

Study arms

  • Experimental
    direct anterior approach with navigation assistance

    Patients treated surgically with total hip arthroplasty (direct anterior approach) with navigation assistance.

    Device: Velys hip navigation

  • Active comparator
    direct anterior approach without navigation assistance

    Patients treated surgically with total hip arthroplasty (direct anterior approach) without navigation assistance.

    Procedure: Standard of care

  • Experimental
    lateral direct approach with navigation assistance

    Patients treated surgically with total hip arthroplasty (lateral direct approach) with navigation assistance.

    Device: Velys hip navigation

  • Active comparator
    lateral direct approach without navigation assistance

    Patients treated surgically with total hip arthroplasty (lateral direct approach) without navigation assistance.

    Procedure: Standard of care

  • Experimental
    postero-lateral approach with navigation assistance

    Patients treated surgically with total hip arthroplasty (postero-lateral approach) with navigation assistance.

    Device: Velys hip navigation

  • Active comparator
    postero-lateral approach without navigation assistance

    Patients treated surgically with total hip arthroplasty (postero-lateral approach) without navigation assistance.

    Procedure: Standard of care

Interventions

  • DeviceVelys hip navigation

    Computer assisted surgery

  • ProcedureStandard of care

    surgery without navigation

06

What researchers measure

Primary outcomes

  1. Legs dysmetria in millimeters calculated in anteroposterior x-rays

    Legs lenght dysmetria in total hip replacement surgery

    Time frame: Intraoperatory

Secondary outcomes

  1. Cup orientation in grade° calculated in anteroposterior x-rays

    Cup orientation in total hip replacement surgery

    Time frame: Intraoperatory

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for May 2027, 35 months after the start.

Of 201 non-industry interventional studies with no phase under Osteoarthritis, Hip, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 35 months is above that.

Counting every sponsor, half of 227 studies reached it within 29 months; a quarter within 14 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 17, 2024
First posted
Jul 17, 2024
StartActual
May 13, 2024
Primary completionEst.
May 12, 2027
CompletionEst.
May 12, 2027
Last update
Jul 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06506201
Responsible party
Sponsor
First posted
Jul 17, 2024
Start date
May 13, 2024
Primary completion
May 12, 2027 (estimated)
Completion
May 12, 2027 (estimated)
Last update
Jul 18, 2025

Study contacts

Federico Raggi, MD
Contact
federico.raggi@ior.it
051 6366122 ext. +39
Federico Raggi, MD
principal investigator · Isitituto Ortopedico Rizzoli

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion